Cell Biotech Co., Ltd. (KOSDAQ:049960)

Market Cap	86.58B
Revenue (ttm)	49.91B
Net Income (ttm)	15.13B
Shares Out	6.84M
EPS (ttm)	2,210.00
PE Ratio	5.72
Forward PE	n/a
Dividend	450.00 (3.56%)
Ex-Dividend Date	Dec 27, 2024

Volume	8,551
Average Volume	14,258
Open	12,930
Previous Close	12,920
Day's Range	12,830 - 13,280
52-Week Range	11,170 - 16,950
Beta	0.64
RSI	29.97
Earnings Date	Mar 20, 2025

About Cell Biotech

Cell Biotech Co., Ltd., a biotechnology company, develops lactic acid bacteria products in South Korea and internationally. It engages in the probiotics, microbiome, and anticancer new drug businesses. The company sells its products through partnerships with multinational companies and local retailers under the DUOLAC, DUOLAB, LACTOClear, and LAB2PRO brand names. Cell Biotech Co., Ltd. was founded in 1995 and is based in Gimpo, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1995
• Employees: 111
• Stock Exchange: KOSDAQ
• Ticker Symbol: 049960

Financial Performance

In 2023, Cell Biotech's revenue was 53.79 billion, an increase of 6.46% compared to the previous year's 50.53 billion. Earnings were 6.30 billion, a decrease of -23.87%.